Parison Amy 4
4 · Editas Medicine, Inc. · Filed Apr 8, 2025
Insider Transaction Report
Form 4
Parison Amy
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-08+34,672→ 34,672 totalExercise: $0.98Exp: 2035-04-07→ Common Stock (34,672 underlying)
Footnotes (1)
- [F1]This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly monthly installments thereafter through April 8, 2029.